Introduction
Induced pluripotent stem (iPS) cells have been obtained from various somatic cell types by forced expression of four transcription factors, Oct4, Sox2, Klf4, and c-Myc, which are subsequently referred to as "Yamanaka factors" [1] [2] [3] [4] [5] [6] [7] . iPS cells are thought to have great potential in cell transplantation therapeutics, because of their embryonic stem (ES) cell-like properties namely selfrenewal and capacity for differentiation into almost all cell types. Furthermore, the iPS technology, especially the recent patient-specific and virus-free iPS cell generation technique overcomes both the ethical issues concerning the use of human embryos and the clinical risk of immune rejection that hinders human ES cell research and application [8] [9] [10] [11] . However, despite several proofof-concept studies suggesting the potential to use iPS to cure diseases such as Parkinson's disease and sickle cell anemia [12, 13] , the therapeutic application of iPS cells remains a long-term goal because of the limited understanding of reprogramming process at the molecular level [14] .
Studies have shown that signaling network is critical to maintain the ground state of pluripotency as well as to control lineage-specific ES-cell differentiation. Mouse ES cells are commonly cultured in medium containing the cytokine leukemia inhibitory factor (LIF) and serum bone morphogenetic proteins (BMPs). LIF is believed to activate the STAT3 signaling pathway to maintain pluripotency while BMP signals act to inhibit differentiation [15, 16] . When cultured in the absence of LIF and BMPs, ES cells can be maintained in a pluripotent state by inhibition of GSK3β signaling together with the elimination of the differentiation-inducing signaling from ERK1/2 mitogen-activated protein kinases [17] . Lineage commitment of ES cells is also regulated by signals either from the environment or intrinsically within the cells. Wnt/ β-catenin signaling is involved in the cardiomyocyte differentiation of mouse ES cells, while induction of ERK1/2 signaling triggers the differentiation of mouse ES cells towards the primitive endoderm lineage [18, 19] . We thus speculate that the signal transduction network must play critical roles during pluripotency induction from somatic cells. Given the diverse origins of iPS cells, systematically studying the fundamental signaling network during reprogramming is of great interest.
Consistent with the critical roles of Yamanaka factors in ES cell pluripotency and iPS cell induction, our previous work reveals that Yamanaka factors regulate a crucial developmental signaling network comprised of 16 signaling pathways, including 9 with previously unknown roles in the maintenance of ES cell pluripotency [20] . In the present study, we identified the promoters occupied by endogenous Yamanaka factors in iPS cells, analyzed their regulated signaling network, and tested the effect of several signaling pathways on Yamanaka factors-induced iPS generation. We also analyzed published data from another iPS cell study [21] , and propose a core developmental signaling network underlying the induction of pluripotency.
Results

Establishment of a completely reprogrammed iPS cell line using an inducible system
We generated an inducible lentivirus expression system for Yamanaka factors ( Figure 1A ) to obtain completely reprogrammed iPS cells. The inducible lentivirus vectors for Yamanaka factors were obtained by separately cloning the coding regions of Oct4, Sox2, c-Myc, and Klf4 into a lentivirus backbone under the control of a TetO-MinCMV promoter ( Figure 1B) , and the viruses were packaged in 293T cells using a second generation of lentivirus recombination system [22] . Mouse embryonic fibroblast (MEF) cells from 129/C57 F1 mice E13.5 embryos were infected overnight with virus containing Oct4, Sox2, c-Myc and Klf4 together with a lentivirus constitutively expressing the reverse tetracycline transactivator (rtTA). The infected MEF cells were cultured first for 2 days in Dulbecco's modified Eagle's medium (DMEM) until they reached confluency and were then reseeded on feeder cell layers in standard mES medium. The medium was changed daily and Dox was added to the medium on day 2 post-infection, and the treatment continued until day 12. Emerged colonies were picked on day 12 and for several subsequent days until enough clones were collected. Finally, eight clones with homogenous ES-like morphology were further expanded in standard mES culture conditions until they formed stable ES-like cell lines. Four of these iPS cell lines, iPS-tet-A1, iPS-tet-B1, iPS-tet-B3, and iPS-tet-F1, were then analyzed for their property of pluripotency. All of them showed an ES-like morphology, were positive for alkaline phosphatase (AP) activity, and endogenously expressed ES pluripotency marker, Nanog ( Figure 1C , shown are the representative data of iPS-tet-B3). We further evaluated the developmental potency of these iPS cell lines by injecting them into the ICR mice blastocysts. Remarkably, all four iPS cell lines tested gave rise to live chimeras with high coat color chimerism ( Figure  1D , Supplementary information, Table S1 ). To test for germline transmission, chimeras derived from iPS-tet-B3 were mated with normal females. Live offsprings with agouti coat color were obtained, showing the origin from iPS cells ( Figure 1D ). iPS cells from clone iPS-tet-B3 were thus used in the following experiments.
Global mapping of promoter occupancy of Yamanaka factors in iPS cells
To characterize the global binding pattern of endogenous Yamanaka factors in iPS cells, iPS-Tet-B3 cells were maintained and expanded in normal mES medium without Dox, and ChIP-chip experiments were performed using the ChIP-grade antibodies against Oct4, Sox2, cMyc, or Klf4 protein and a Mouse Promoter Tiling Microarray Set covering [−8 kb, +2.5 kb] (from transcriptional start sites, TSS) promoters of about 17 kb RefSeq transcripts [20] . Target genes for Yamanaka factors were identified using Agilent G4477AA ChIP Analytics 1.3.1 software, where the "binding peak" in promoter regions and the binding activity of the four factors were inferred from Agilent's error modeling. The binding positions Table S2 . Similar to what we previously performed in ES cells [20] , the high quality nature of the ChIP-chip data is further validated using ChIP-qPCR assays with primer sets for several well-known target loci of each of the Yamanaka factors (data not shown).
The number of target genes of Oct4, Sox2, Klf4, and c-Myc is 1 388, 1 372, 1 832, and 2 531, respectively (Figure 2A) , which is similar to the data that we obtained in ES cells [20] as well as the data published recently [21] . Most target sites of these four factors are enriched in proximity to TSS (approximately ±2 kb from TSS) ( Figure  2B ), which is also observed in ES cells [20] , confirming the reproducibility of our ChIP-chip experiment. To gain further insights into the binding pattern of the Yamanaka factors, we analyzed the number of target genes for each individual factor and different combinations of the four factors, and compared them with those in ES cells ( Figure  2C , Supplementary information, Figure S1 ). Surprisingly, although the total number of target genes for each individual factor is largely the same within these two datasets, the number of target genes for different combinations of factors is quite different between iPS and ES cells. The total number of target genes occupied by only one factor is 4 000 in ES cells (Supplementary information, Figure S1 ), whereas the number in iPS cells is only 1 584. The number of target genes co-occupied by two factors only is also reduced from 1 083 in ES cells to 733 in iPS cells. In contrast, the number of target genes co-occupied by at least three factors or four factors is significantly increased. In iPS cells, the number of genes co-occupied by at least three factors is 1 104, a threefold increase compared to that in ES cells. Figure  S2 ).
We then analyzed the possible effects of differential binding of the Yamanaka factors on the expression pattern of the target genes by supervised clustering and gene set enrichment analysis (GSEA) ( Figure 3A) . In ES cells, previous studies showed that genes occupied by only one of the non-c-Myc factors (Oct4, Sox2, or Klf4) were largely repressed, while genes occupied by two or more factors were activated [20] . However, in iPS cells, we found that the expression of target genes bound by nonc-Myc factors showed a balanced pattern, with almost equal number of activated and repressed genes, no matter whether they were targeted by only one single factor or by multiple factors ( Figure 3B-3D) . Notably, while cMyc mainly functions as an activator of gene expression [20] in ES cells, c-Myc target genes in iPS cells show a balanced expression pattern, regardless of being targeted by c-Myc alone or together with other factors ( Figure  3B, 3C) . Coincidently, in another recently published iPS ChIP-chip dataset, the targets of Oct4, Sox2, and Klf4 also show a nearly balanced expression pattern when bound by a single factor alone or by two factors together, while targets co-bound by Oct4, Sox2, and Klf4 together are largely repressed, and c-Myc mainly functions as a suppressor of gene expression (Supplementary information, Figure S3 ). Collectively, these data indicate that Yamanaka factors play some distinct roles in ES and iPS cells, with more synergetic effects on regulation of gene transcription in iPS cells.
Characterization of signaling pathways regulated by Yamanaka factors in iPS cells
To investigate the signaling network regulated by Yamanaka factors in iPS cells, we analyzed our iPS data using PANTHER (Protein ANalysis Through Evolutionary Relationships, http://www.pantherdb.org/), as we did in ES cells [20] , and compared the two cases. The primary categorization of KEGG pathways is shown in Supplementary information, Table S3 and the pathways regulated by each and multiple Yamanaka factors are listed  in upplementary information, Tables S3-S7 . In iPS cells, the genes only bound by one of the three non-c-Myc factors (Oct4, Sox2, or Klf4) are enriched mainly in developmental processes and mRNA transcription processes, while genes bound by c-Myc alone are mainly enriched in the protein metabolism and modification systems (Figure 4A ). These observations are consistent with that in ES cells [20] . However, when the total targets of c-Myc were analyzed, they were found to be enriched significantly in metabolism system, as well as in developmental processes and mRNA transcription processes ( Figure  4B ), which is not the case in ES cells [20] . Interestingly, in iPS cells the union target genes of Oct4, Sox2, and Klf4 are also enriched in the metabolism process ( Figure  4B ). Further analysis of target genes in different combinations of the four factors revealed that the targets of Oct4 and Sox2 are enriched in both developmental and metabolism processes either with or without c-Myc and Klf4 ( Figure 4C, 4D ). This suggests that in iPS cells, in addition to their role in developmental signaling, Oct4 and Sox2 may act together to function as metabolism regulators, which is not observed in ES cells [20] . Similarly, PANTHER analysis of c-Myc target genes gave similar results (Supplementary information, Figure S4 ). To investigate the synergistic effect of Yamanaka factors in iPS cells, we analyzed the hierarchical clustering of the four factors on the basis of their targets correlations. Interestingly, although the correlation between Oct4 and Sox2 remains similarly highest in ES and iPS cells (0.521 and 0.626, respectively), the correlation between other factors becomes closer in iPS than in ES cells ( Figure  4E ). The most striking difference is again in c-Myc. In ES cells, our previous analysis shows that c-Myc correlated poorly to the other three factors, with the correlation coefficients with Oct4, Sox2, and Klf4 being −0.223, −0.249, −0.294, respectively [20] . However, in iPS cells, the correlation coefficients of c-Myc with Oct4, Sox2, and Klf4 are 0.356, 0.337, and 0.282, respectively (Figure 4E ). Our analysis of another recently published iPS dataset [21] shows similar results (Supplementary information, Figure S5 ) and the enriched pathways identified using these data are listed in Supplementary information, Table S8 . All together, these data indicate that in iPS cells, the four Yamanaka factors function more synergistically with each other in regulating developmental signaling as well as other processes.
Defining a signaling network controlling pluripotency in iPS cells
To further explore how the Yamanaka factors are involved in regulating signaling pathways in iPS cells, we used KOBAS [23, 24] to clarify the pathways regulated by the four factors into subcategories of development, cancer, metabolism, and other signaling pathways ( Figure  5A ). Consistent with the results from PANTHER analysis, the distributions of pathways regulated by Yamanaka factors between different subcategories in iPS cells also differ from those in ES cells. In iPS cells, c-myc regulates 38 signaling pathways. Out of them, 16 are developmental signaling pathways. However, in ES cells, c-myc only regulates 9 develpomental signaling pathways out of 47 total regulated pathways. The number of developmental signaling pathways related to Klf4 is 13 out of 29 in iPS cells, but 6 out of 32 in ES cells. Moreover, although ES and iPS cells share most of the developmental signaling pathways identified (12 out of 16 pathways overlap), they do have some differences ( Figure  5B ). Four signaling pathways we previously identified in ES cells [20] , axon guidance, cytokine-cytokine recep-
npg Figure 4 Functional analysis of cell signaling role of Yamanaka factors' targeted genes using PANTHER classification system. The y-axis represents the relative enrichment calculated as the following: the obtained number of genes in our binding lists for "developmental process", "mRNA transcription", "protein metabolism and modification", and "cell cycle" is divided by the expected number of genes calculated for all mouse genes. The values above and below one indicate the enrichment or depletion of the target genes in the category, respectively. The numbers above each bar represents "the genes included in the category"/"the genes expected in the category". All targets occupied by Oct4, Sox2, Klf4, or c-Myc, and the targets occupied by Oct4, Sox2, Klf4, or c-Myc only were separately analyzed in (A) and (B). Target genes were mainly enriched during developmental process and mRNA transcription. (C) "Oct4 plus Sox2" represents the core cluster genes that are occupied by the factors containing Oct4 or Sox2; "Oct4 plus Sox2 only" represents the genes occupied by the factors containing Oct4 or Sox2, but not Klf4 and c-Myc; "Oct4 plus Sox2 and Klf4" represents the "Oct4 plus Sox2" genes co-occupied by Klf4; "Oct4 plus Sox2 and c-Myc" represents the "Oct4 plus Sox2" genes co-occupied by c-Myc; "Oct4 plus Sox2 and Klf4 and c-Myc" represents the "Oct4 plus Sox2" genes co-occupied by Klf4 and c-Myc together. The "Oct4 plus Sox2 and c-Myc only" core genes were enriched during the developmental processes, mRNA transcription, and cell cycle, but not during the protein metabolism. Each of the combination has lower relative enrichment in protein metabolism. (D) "Oct4 plus Sox2 plus Klf4" represents the core cluster of genes that are occupied by the factors containing Oct4, Sox2, or Klf4. "Oct4 plus Sox2 plus Klf4 only" represents the genes occupied by the factors containing Oct4, Sox2, or Klf4, but not c-Myc; "Oct4 plus Sox2 plus Klf4 and c-Myc" represents the "Oct4 plus Sox2 plus Klf4" genes co-occupied by c-Myc. The "Oct4 plus Sox2 plus Klf4" core genes were highly enriched during developmental processes, mRNA transcription, and cell cycle. In protein metabolism, each of the combination still has lower relative enrichment. tor interaction, dorsal-ventral axis formation, and Notch signaling pathways, are not identified in iPS cells, while VEGF signaling pathway, calcium signaling, tight junction, and mTOR signaling pathways are unique to iPS cells ( Figure 5B ). We also similarly analyzed another published ChIP-chip data on iPS cells and partially reprogrammed iPS (piPS) cells [21] for signaling pathways regulated by Yamanaka factors and obtained similar re- Figure S6 ). On the basis of these observations, we experimentally tested the effect of MAPK signaling, one repressive regulator in iPS cell induction identified by us, and found that inhibition of the JNK and Erk1/2 MAPK pathways indeed significantly improves iPS cell generation efficiency ( Figure 6 ). Finally, we compared these four groups of pathways found in ES and iPS cells, and identified a core developmental signaling network regulated by Yamanaka factors ( Figure 5C ). Totally, eight 
Discussion
In the present study we focused on the signaling network regulated by the Yamanaka factors during the The numbers of GFP-positive colonies on the twelfth day post-infection upon four-factor induction (Ctrl), four-factor induction plus VPA (2 mM), fourfactor induction plus p38 inhibitor SB203580 (1 µM), four-factor induction plus JNK inhibitor SP600125 (10 µM), and two ERK inhibitors, PD98059 (10 µM) and U0126 (10 µM), were counted and normalized as fold increase relative to Ctrl. Statistics were carried out by one-way ANOVA followed by LSD post hoc test. *P < 0.05, **P < 0.01, ***P < 0.001.
iPS datasets, 10 pathways are identical, including Wnt, Jak-STAT, MAPK, p53, TGF-β, VEGF, Hedgehog, adherens junction, cell cycle, and focal adhesion signaling pathways. Collectively, despite the differential binding of Yamanaka factors in two different ES cells [20, 21] and different iPS cells, the signaling pathways revealed by these datasets are highly overlapped. ChIP-chip plus pathway analysis is thus a powerful tool for discovering the molecular mechanisms of the reprogramming process. In Yamanaka factor-regulated core signaling pathways, the role of some pathways in cell reprogramming has been confirmed. Wnt signaling and p53 signaling pathways were known to be regulated by Yamanaka factors in both iPS and ES cells, and their role in Yamanaka factors-induced reprogramming or in cell fusionmediated reprogramming has been proven recently [25, 26] . Calcium signaling pathway is not a previously reported pathway related with pluripotency, however, it was found to be an active regulator in iPS cells by our data. Interestingly, the improvement of reprogramming efficiency through activation of calcium signaling has been recently discovered through a large-scale screening of small chemicals [27] . PI3K signaling pathway was found in piPS cells, while the MAPK signaling pathways, including JNK, ERK1/2 and p38 MAPK pathways were identified as repressive regulators in iPS cells, and the functions of JNK, ERK1/2, and PI3K signaling pathways in induction of pluripotency were also confirmed by our experiments (Figure 6 and data not shown). These results provide further evidence for the quality of data and significance of our ChIP-chip plus pathway analysis, suggesting that our study not only reveals knowledge about the signaling nature of iPS and ES cells, but also provides useful insights for the development of new reprogramming methods. Further exploration of the roles of pathways with previously unknown functions in cell pluripotency maintenance such as mTOR signaling, tight junction signaling and GnRH signaling pathways in the reprogramming process will be of great interest to reveal the specific roles of these pathways and Yamanaka factors during cell reprogramming and development.
Consistent with the specific identity of different ES and iPS cell lines [20] , we noticed that there are some differences between the pathways obtained from using our data and those from another published data ( Figure  5B, Supplementary information, Figure S6C ). In our data, there are 16 developmental signaling pathways regulated by Yamanaka factors in iPS cells, while 14 enriched pathways are identified in another recently published iPS dataset. Interestingly, among these two datasets, 10 pathways are overlapped. When the data from ES reprogramming process. By analyzing the genome-wide promoter occupancy of the four factors, we provide a set of data about different signaling pathways that may regulate pluripotency, which may be a useful resource for researchers in both ES and iPS cell community. We also carried out signaling pathway analysis from another recently published ChIP-chip dataset on the promoter occupancy of the four factors in ES and iPS cells [21] . We identified a core developmental signaling network regulated by Yamanaka factors through analyzing and comparing the developmental signaling pathways from the four ChIP-chip datasets ( Figure 5 , Supplementary information, Figure S6 ). We found that 12 developmental signaling pathways overlap between the 16 pathways obtained each from our iPS cell data and those from our ES cell data, while a recently published ChIP-chip dataset [21] identified 15 and 14 developmental signaling pathways in ES and iPS cells, respectively, among which 12 are identical. Furthermore, between the two 1136 and iPS cells are analyzed, eight pathways including Jak-STAT, Wnt signaling, TGF-β, p53, Hedgehog, cell cycle, adherens junction, and focal adhesion pathways are identified as core pathways that associate with pluripotency. VEGF signaling is not found in our ES data ( Figure 5B ) and MAPK signaling is not found in the published ES data (Supplementary information, Figure S6C ). Meanwhile, four pathways, axon guidance, CAM ligands, ECM-receptor interaction and Notch signaling are enriched in the published iPS and ES data, while six pathways, apoptosis, calcium signaling, ErbB, gap junction, mTOR and tight junction are not enriched in the recently published iPS data [21] . These observations indicate that despite the many similarities, different iPS cell lines may possess some specific characteristics. Thus, properties of ES and iPS cells should be fully investigated and optimized before the application of specific iPS cells.
In addition to the developmental and signaling pathways discussed above, we also investigated other pathways such as metabolism pathways. We found that the following pathways were highly enriched in ES and iPS cells, but not in piPS cells. These include hypoxia signaling, VDR/RXR activation, CCR3 signaling, cell cycle G1/S checkpoint regulation, calcium-induced apoptosis, IGF-1 signaling, Aryl hydrocarbon receptor signaling, ephrin receptor signaling, protein ubiquitination pathway, mitochondria dysfunction, etc. In contrast, pathways such as clathrin-mediated endocytosis and actin cytoskeleton signaling were enriched in piPS cells but not in iPS cells or ES cells. Further exploration of these unexpected pathways may give us insights about pluripotency and cell reprogramming.
In summary, through ChIP-chip plus pathway analysis of promoter occupancy of Yamanaka factors, we found that Yamanaka factors function more synergistically in iPS cell induction, and identified Yin-Yang-balanced developmental signaling pathways in maintaining and regenerating cell pluripotency. Our study thus not only provides a useful resource and a powerful methodology to understand the nature of induced pluripotency, but also provides a variety of potential choices to improve the iPS cell induction efficiency through specific signaling pathway activators or inhibitors. Further exploration of the similarity and difference between piPS, iPS, and ES cells revealed here will open new doors to understand the molecular nature of cell reprogramming and development.
Materials and Methods
Virus production and iPS cell generation
The coding region of Oct4, Sox2, c-Myc, and Klf4 were amplified from pMXs-Oct4, pMXs-Sox2, pMXs-c-Myc, and pMXsKlf4 plasmids (purchased from Addgene), respectively, and inserted between the BamHI and SalI site in the Lv-Tre lentivirus vector following BamHI/XhoI double digestion. The constitutively expressed rtTA lentivirus vector was a kind gift of Dr Lei Xiao. All plasmids were sequenced before being used in our experiments.
Viruses were produced in 293T cells using a second generation of lentivirus packaging system. Briefly, 4.0×10 6 293T cells were transfected with 10 µg of the lentivirus vector together with 7.5 µg of the delta-8.91 vector and 5 µg of the VSVG vector following the standard calcium transfection procedure. Viruses were harvested 48 h after transfection, filtered through a 0.45 µM filter, and stored at 4 ºC before use.
MEF cells were generated from the E13.5 129/C57 F1 mice embryos, as previously described [1] . For iPS cell induction, 8×10 4 MEF cells were seeded in a 35-mm plate. At 12 h after seeding, 1 ml each of the Oct4, Sox2, c-Myc, Klf4, and rtTA virus was mixed and added to the MEF culture. Polybrene was added to the culture in a final concentration of 8 µg/ml. At 24 h after infection, the viruses were removed. Infected MEF cells were then cultured in DMEM for 2 days and reseeded on irradiated MEFs at a density of 1.0×10
4 cells/cm 2 in typical mES cell media consisting of DMEM (GIBCO) supplemented with 15% heat-inactivated fetal bovine serum (GIBCO), 0.055 mM beta-mercaptoethanol (GIBCO), 2 mM L-glutamine, 0.1 mM MEM non-essential amino acid, and 1 000 U/ml LIF (Chemicon). Potential iPS colonies began to appear 12 days after infection. These colonies were individually picked and expanded for further analysis.
Immunostaining and AP staining
iPS cells were seeded at a density of 1.0×10 4 cells/cm 2 on irradiated MEFs in 24-well plates and immunostained for Nanog expression 2 days later. Briefly, cells were washed twice with PBS, fixed with 4% PFA/PBS for 30 min, permeablized with 0.2% Triton X-100 for 10 min, and blocked with 1% BSA/PBS for 2 h. Cells were then incubated with a primary antibody against Nanog (Santa Cruz, Catalog number sc-33760) diluted 1:100 in 1% BSA/ PBS for 2 h, washed twice with 1% BSA/PBS, incubated with a Texas-red conjugated secondary antibody diluted 1:100 in 1% BSA/PBS for 2 h, washed twice with 1% BSA/PBS, covered with PBS, and scanned for fluorescence under a microscope.
For AP staining, iPS cells were seeded on irradiated MEFs in 24-well plates at a density of 1.0×10 4 cells/cm 2 . At 2 days after seeding, AP staining was carried out using an Alkaline Phosphatase Detection Kit (Chemicon, Catalog number SCR004), following the manufacturers instructions.
Blastocyst injections
Blastocysts derived from ICR mice were placed in a drop of DMEM with 15% FCS under mineral oil. A flat tip microinjection pipette was used for iPS cell injection. After injection, blastocysts were transferred to each uterine horn of 2.5-day post-coitum pseudo-pregnant females. For test of germline transmission, chimeras derived from iPS cells were mated with normal ICR females.
Chromatin immunoprecipitation and hybridization
Chromatin immunoprecipitation and hybridization were carried out following the standard Agilent mammalian ChIP-chip protocol 9.1 (available online: http://www.chem.agilent.com/scripts/ generic.asp?lpage=11617&indcol=N&prodcol=Y), as previously described [20] . Briefly, iPS-tet-B3 cells were grown to a final www.cell-research.com | Cell Research Jinyan Huang et al. 1137
npg count of 1×10 8 cells for each ChIP-chip experiment. Cells were harvested with diastase and chemically cross-linked in 50 ml of 0.5% formaldehyde for 20 min at room temperature. Cells were then rinsed twice with 50 ml of 1× PBS and stored at −80 ºC prior to use. Cells were resuspended and lysed in lysis buffers, and then sonicated to shear the cross-linked DNA to an average length of 500 bp. Since the sonication conditions vary mainly depending on cell line, cell number, degree of cross-linking, and equipment, we used a Bioruptor sonicator (Diagenode) and sonicated the 1×10 8 iPS cells with intensity set at high for 26×15-s pulse (30-s pause between each pulse) at 4 ºC, while the samples were kept immersed in an ice-water bath. In total, 50 µl of the sonicated lysate was saved for whole-cell extract (WCE) DNA extraction. The remaining lysate was incubated overnight at 4 ºC with 100 µl of Dynal Protein A magnetic beads pre-incubated with 10 µg of specific antibody. The Dynal beads were washed five times with RIPA buffer and once with TE containing 50 mM NaCl. To elute the bound complex from beads, 210 µl of the elution buffer was added and the beads were incubated for 15 min at 65 ºC with interval vortexing at every 2 min. As for the WCE DNA extraction, 150 µl of elution buffer was added to 50 µl of the sonicated lysate. Both the immunoprecipitated DNA sample eluted from the Dynal beads and the WCE DNA sample were incubated overnight at 65 ºC to reverse the chemical cross-linking between protein and DNA. The DNA samples were then purified by treatment with RNaseA, proteinase K, and phenol:chloroform:isoamyl alcohol extraction. Purified DNA was treated with Whole Genome Amplification Kit (WGA2, Sigma) [28] , which allowed more linear amplification of a small amount of DNA than traditional ligation-mediated PCR [29] . We used a standard protocol for modified WGA amplification (http://www.genomecenter.ucdavis.edu/farnham/protocol. html). Amplified DNA was labeled and purified using Invitrogen Bioprime random primer labeling kits (immunoprecipitated DNA was labeled with Cy5 fluorophore; WCE DNA was label with Cy3 fluorophore). The labeled IP and WCE DNA were combined in equal amounts (5 µg) and hybridized to mouse promoter arrays in Agilent hybridization chambers for 40 h at 65 ºC. After washing, slides were scanned and analyzed. At least three biological replicates of hybridization were performed for each sample.
Array design and data extraction
The Mouse Promoter ChIP-on-chip Microarray Set used in this study was manufactured by Agilent Technologies (http://www. agilent.com). Each microarray set (product number: G4490A) contains two slides (design number: slide 1=014716 and slide 2=014717) that cover [−8 kb, +2.5 kb] (from transcriptional start sites, TSS) promoters of ~17 000 mouse RefSeq transcripts. These arrays were designed on the basis of the UCSC mm8, NCBI build 36 mouse genome (February 2006). Data were extracted from image files by Feature Extraction V9.5.3.1, and peak analysis was performed using Agilent ChIP Analytics V1.3.1.
Microarray data processing
The gene expression data were retrieved from a previous study [21] , in which RNA was extracted from duplicate samples of V6.5 and E14 ES cells, 1D4 and 2D4 iPS cells, 1A2 and a single sample of 1B3 partially reprogrammed cells, and four samples of three different MEF lines. The gene expression data were then analyzed by GSEA, which is a computational method that determines whether an a priori defined set of genes shows statistically significant, concordant difference between two biological states or phenotypes [30, 31] . Experimental expression values were analyzed by GSEA.
In order to produce the supervised clustering image given in Figure 3A (left panel), we first performed unsupervised hierarchical clustering of the transcription factors on the basis of the correlation of their target genes, using Cluster and Treeview software [32] . To produce a cluster view of common targets of multiple factors and unique targets of single factor, we first randomized the order of target genes and then sequentially sorted targets of each factor. For the target gene expression profile image given in Figure  3A (right panel), the expression value of each gene on iPS was measured by duplicate 1D4 and 2D4, and four samples of three different MEF lines were averaged. We then applied moving window average on the expression values of target genes in the order determined in Figure 3A (left panel).
PANTHER analysis
Gene ontology analysis was performed with the Panther Classification System. The analysis procedure consists of uploading Yamanaka target gene list into the system and submitting the list. The map lists genes to a PANTHER ontology. The binomial statistics tool is used to compare classifications of multiple clusters of lists to a reference list to statistically determine over-or underrepresentation of PANTHER classification categories. The results of the target genes of each transcription factor were combined and compared to produce Figure 4 .
Visualization of signaling pathway network
Cytoscape software version 2.6.2 [36] was used to visualize the signaling regulatory networks shown in Figure 5C .
